Immune attributes of cardiac-derived adherent proliferating (CAP) cells in cardiac therapy

Journal of Tissue Engineering and Regenerative Medicine

Volumn 7, Issue 5, 2013, Pages 362-370

  Haag, Marion ^a   Stolk, Meaghan ^a   Ringe, Jochen ^a   Linthout, Sophie Van ^a   Tschöpe, Carsten ^a   Sittinger, Michael ^a   Seifert, Martina ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cardiac cells; Cell therapy; Cytokines; Immunogenicity; Inflammation; Regulatory cells

Indexed keywords

CELL PROLIFERATION; DISEASE CONTROL; DISEASES; T-CELLS;

CARDIAC CELL; CELL THERAPY; CO-CULTURES; CYTOKINES; IMMUNE CELLS; IMMUNOGENICITY; PERIPHERAL BLOOD LYMPHOCYTES; PHYTOHAEMAGGLUTININ; PROLIFERATING CELLS; REGULATORY CELL;

HEART;

ALLOANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; PHYTOHEMAGGLUTININ; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CARDIAC DERIVED ADHERENT PROLIFERATING CELL; CD25+ T LYMPHOCYTE; CELL ACTIVATION; CELL ISOLATION; CELL PROLIFERATION; CELL THERAPY; CONTROLLED STUDY; CYTOKINE RELEASE; FLOW CYTOMETRY; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; IMMUNOMODULATION; IMMUNOPHENOTYPING; INFLAMMATION; LYMPHOCYTE CULTURE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

EID: 84877117402     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.531     Document Type: Article

References (41)

1. Afzali B, Lechler RI, Hernandez-Fuentes MP. 2007; Allorecognition and the alloresponse: clinical implications. Tissue Antigens 69(6): 545-556.
2. Aggarwal S, Pittenger MF. 2005; Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105(4): 1815-1822.
3. Bartholomew A, Sturgeon C, Siatskas M et al. 2002; Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30(1): 42-48.
4. Battula VL, Treml S, Bareiss PM et al. 2009; Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica 94(2): 173-184.
5. Boyle AJ, McNiece IK, Hare JM. 2010; Mesenchymal stem cell therapy for cardiac repair. Methods Mol Biol 660: 65-84.
6. + regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD). Cell Immunol 258(1): 65-71.
7. Chinen J, Buckley RH. 2010; Transplantation immunology: solid organ and bone marrow. J Allergy Clin Immunol 125(2, suppl 2): S324-335.
8. Crop MJ, Baan CC, Korevaar SS et al. 2009; Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients. Transplantation 87(6): 896-906.
9. Crop MJ, Baan CC, Korevaar SS et al. 2010; Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation. Stem Cells Dev 19(12): 1843-1853.
10. Di Nicola M, Carlo-Stella C, Magni M et al. 2002; Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99(10): 3838-3843.
11. English K, Wood KJ. 2011; Immunogenicity of embryonic stem cell-derived progenitors after transplantation. Curr Opin Organ Transpl 16: 90-95.
12. Fairchild PJ. 2010; The challenge of immunogenicity in the quest for induced pluripotency. Nat Rev Immunol 10(12): 868-875.
13. Griffin MD, Ritter T, Mahon BP. 2010; Immunological aspects of allogeneic mesenchymal stem cell therapies. Hum Gene Ther 21(12): 1641-1655.
14. Haag M, Van Linthout S, Schroder SE et al. 2010; Endomyocardial biopsy-derived adherent proliferating cells - a potential cell source for cardiac tissue engineering. J Cell Biochem 109(3): 564-575.
15. Hoogduijn MJ, Crop MJ, Peeters AM et al. 2007; Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. Stem Cells Dev 16(4): 597-604.
16. Huang XP, Sun Z, Miyagi Y et al. 2010; Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation 122(23): 2419-2429.
17. Jiang B, Liao R. 2010; The paradoxical role of inflammation in cardiac repair and regeneration. J Cardiovasc Transl Res 3(4): 410-416.
18. Jiang XX, Zhang Y, Liu B et al. 2005; Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105(10): 4120-4126.
19. Jiao J, Milwid JM, Yarmush ML et al. 2011; A mesenchymal stem cell potency assay. Methods Mol Biol 677: 221-231.
20. Karabekian Z, Posnack NG, Sarvazyan N. 2011; Immunological barriers to stem cell-based cardiac repair. Stem Cell Rev 7(2): 315-325.
21. Kleinbongard P, Heusch G, Schulz R. 2010; TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther 127(3): 295-314.
22. Klyushnenkova E, Mosca JD, Zernetkina V et al. 2005; T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci 12(1): 47-57
23. Kuci S, Kuci Z, Kreyenberg H et al. 2010; CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties. Haematologica 95(4): 651-659.
24. Ladhoff J, Fleischer B, Hara Y et al. 2010; Immune privilege of endothelial cells differentiated from endothelial progenitor cells. Cardiovasc Res 88(1): 121-129.
25. Le Blanc K, Tammik C, Rosendahl K et al. 2003; HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31(10): 890-896.
26. Maccario R, Moretta A, Cometa A et al. 2005; Human mesenchymal stem cells and cyclosporin a exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes. Biol Blood Marrow Transpl 11(12): 1031-1032.
27. McGettrick AF, O'Neill LA. 2007; Toll-like receptors: key activators of leucocytes and regulator of haematopoiesis. Br J Haematol 139(2): 185-193.
28. Nauta AJ, Fibbe WE. 2007; Immunomodulatory properties of mesenchymal stromal cells. Blood 110(10): 3499-3506.
29. Potian JA, Aviv H, Ponzio NM et al. 2003; Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 171(7): 3426-3434.
30. Ramasamy R, Tong CK, Seow HF et al. 2008; The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function. Cell Immunol 251(2): 131-136.
31. Rasmusson I. 2006; Immune modulation by mesenchymal stem cells. Exp Cell Res 312(12): 2169-2179.
32. Rasmusson I, Ringden O, Sundberg B et al. 2005; Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 305(1): 33-41.
33. Reinisch A, Bartmann C, Rohde E et al. 2007; Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. Regen Med 2(4): 371-382.
34. Ren G, Zhao X, Zhang L et al. 2010; Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol 184(5): 2321-2328.
35. Rogers TB, Pati S, Gaa S et al. 2011; Mesenchymal stem cells stimulate protective genetic reprogramming of injured cardiac ventricular myocytes. J Mol Cell Cardiol 50(2): 346-356.
36. Saalbach A, Klein C, Sleeman J et al. 2007; Dermal fibroblasts induce maturation of dendritic cells. J Immunol 178(8): 4966-4974.
37. + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6(4): 345-352.
38. Spees JL, Gregory CA, Singh H et al. 2004; Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 9(5): 747-756.
39. Uccelli A, Moretta L, Pistoia V. 2006; Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 36(10): 2566-2573.
40. Van Linthout S, Savvatis K, Miteva K et al. 2011; Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis. Eur Heart J 32(17): 2168-2178.
41. Zhang W, Ge W, Li C et al. 2004; Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev 13(3): 263-271.